




























factor,	an	evolutionarily	 conserved	hub	 that	 links	DNA	replication,	DNA	repair	and	chromosome	





subunit	 GINS	 Sld5.	 By	 screening	 stapling	 positions	 in	 the	 Sld5	 CIP	 sequence,	 we	 identified	 an	








Targeting	 cancer	 cells	 with	 DNA-damaging	 agents	 such	 as	 cis-platin	 is	 a	 mainstay	 of	 traditional	
chemotherapy,	and	its	effectiveness	might	reflect	the	underlying	fragility	of	cancer	cells	in	maintaining	
their	genomic	stability1.	More	recently,	the	concept	of	synthetic	lethality	as	the	Achilles	heel	of	cancer	
cells	 with	 defective	 pathways	 of	 genome	 stability	 maintenance	 has	 taken	 firm	 hold,	 since	 the	




currently	 used	 in	 clinical	 practice.	 As	DNA	 replication	 and	 repair	 processes	 cooperate	 to	 preserve	
genomic	 integrity,	 synthetic	 lethality	 effects	 might	 exist,	 and	 should	 be	 searched	 for,	 among	 all	
chromosome	instability	(CIN)	genes.		
A	distinctive	feature	of	metabolic	processes	such	as	DNA	replication,	repair	and	transcription	is	the	
high	degree	of	 conservation	of	 their	protein	 components	among	eukaryotes.	 This	observation	has	
recently	 been	 exploited	 to	 screen	 CIN	 genes	 in	 yeast,	 as	 a	 quick	 way	 of	 identifying	 potentially	
druggable	candidates	displaying	synthetic	lethality	with	DNA	repair	genes	that	are	often	mutated	in	
human	cancers8,9.	Such	analysis	highlighted	Ctf4	(Chromosome	Transmission	Fidelity	4)10,11	as	a	highly	
promising	 candidate,	 at	 a	 centre	 of	 a	web	 of	 negative	 genetic	 interactions	with	 other	 CIN	 genes.	
Moreover,	the	same	appears	to	be	true	for	the	human	orthologue	of	yeast	Ctf4,12.	The	high	level	of	
genetic	connections	involving	Ctf4	is	likely	to	reflect	its	known	role	as	a	protein	hub	linking	different	






site	 on	 the	 helical	 domain	 of	 Ctf4,	 fused	 to	 Ctf4’s	 second	 b-propeller	 domain	 (Figure	 1)13,14.	 The	
interaction	 is	 of	 moderate,	 micromolar	 affinity	 and	 represents	 an	 example	 of	 the	 SLIM-protein	
interactions	that	characterise	the	dynamic	architecture	of	the	replisome17.	The	determination	of	the	
structural	 basis	 for	 the	 interaction	 of	 Ctf4	with	 its	 client	 proteins	 has	 afforded	 an	 opportunity	 to	
develop	a	strategy	for	targeting	Ctf4,	by	interfering	with	its	function	as	a	protein	hub.	
Targeting	 protein-protein	 interfaces	 (PPIs)	 as	 a	 means	 of	 specifically	 disrupting	 the	 association	
between	macromolecules	would	increase	greatly	the	range	of	druggable	protein	targets,	and	a	lot	of	
effort	 has	 gone	 into	 developing	 effective	 PPI	 inhibitors18-20.	 Traditional	 small	 molecule	 library	
approaches	are	often	not	suitable	for	inhibiting	PPIs	though,	as	such	interfaces	consist	usually	of	large	
and	relatively	 flat	 surfaces.	A	promising	approach	to	generate	a-helical	PPI	 inhibitors	 is	 the	use	of	
conformationally-constrained	 peptides,	 often	 referred	 to	 as	 ‘stapled	 peptides’,	 especially	 when	
referring	to	a	peptide	constrained	 into	an	a-helical	conformation21-23.	 In	addition	to	their	potential	
value	as	 inhibitors,	stapled	peptides	represent	useful	proof-of-principle	tools	 to	 identify	 targetable	


























We	had	previously	 found	 that	 the	GINS	subunit	Sld5	 is	 responsible	 for	anchoring	Ctf4	 to	 the	CMG	
helicase,	and	showed	that	binding	is	mediated	by	the	interaction	of	a	short	sequence	motif	of	Sld5	
(Ctf4-interacting	 peptide	 or	 CIP;	 1-MDINIDDILAELDKETTAV-19)	 with	 an	 exposed	 site	 in	 the	 helical	
domain	of	 the	Ctf4CTD	 structure13	 (Figure	3A).	Alanine-scanning	mutagenesis	had	 revealed	 that	 the	
hydrophobic	amino	acids	I5,	I8	and	L9	at	the	binding	interface	were	critical	for	interaction	with	Ctf413.	
Keeping	 the	 key	 residues	 in	 place,	 four	 different	 stapling	 positions	 were	 designed	 into	 the	 Sld5	
sequence	by	inspection	of	the	Ctf4CTD-Sld5	complex	structure	(PDB	id:	4c95),	including	two	sequences	
with	conventional	stapling	at	i,i+7	and	two	unorthodox	i,i+6	and	i,i+8	staplings	(Figure	3B).	The	diazido-
peptides	 CF-A,	 CF-B,	 CF-C,	 CF-D	 (Figure	 3B),	 where	 ‘CF’	 represents	 N-terminal	 capping	 with	 5(6)-











As	 the	Sld5	peptide	A1,	stapled	at	positions	 i,	 i+6,	 showed	 the	 strongest	binding	 to	Ctf4CTD,	 it	was	






for	 chemical	 derivatisation	 of	 the	 staple	 which	 could	 be	 exploited	 for	 instance	 to	 improve	 cell	
permeabilization26,28,	while	 still	 retaining	dissociation	constants	 that	are	2.7-fold	 stronger	 than	 the	
wild-type	peptide.		
FP	analysis	of	A2	showed	that	 its	binding	to	Ctf4CTD	was	one	order	of	magnitude	stronger	than	the	
wild-type	 peptide	 (Sld51-19).	 To	 confirm	 this	 improvement	 in	 the	 binding	 strength	 to	 Ctf4,	 we	
performed	a	competition	experiment	using	CF-A2	peptide	bound	to	Ctf4CTD,	and	competed	off	 the	








largely	 unfolded	 in	 aqueous	buffer	 (Figure	5),	 and	 that	 addition	of	 tri-fluoroethanol	 (TFE)	 induced	














































Sld5	 CIP	 was	more	 effective	 at	 lower	 concentrations	 than	 the	 wild-type	 Sld5	 CIP	 (Figure	 8B).	 	 In	
contrast	 to	 the	 complete	disruption	 achieved	 for	 the	 association	of	 Pol	a	with	 the	 replisome,	 the	
stapled	version	of	the	Sld5	CIP	had	a	more	modest	effect	on	the	association	of	Ctf4	with	the	CMG	
helicase	(Figure	8B).		This	is	consistent	with	our	past	data	showing	that	mutation	of	the	Sld5	CIP	does	





















potential	 of	 stapled	 peptides	 to	 inhibit	 Ctf4	 function	 in	 cells	 and	 tissues,	 perhaps	 by	 systematic	
derivatisation	of	the	stapling	group,	which	is	facilitated	by	our	two-component	double-click	stapling	
technique.	Furthermore,	our	proof-of-concept	work	with	 stapled	peptides	will	 serve	 to	 inspire	 the	
development	of	small-molecule	inhibitors	with	different	pharmacological	properties.		
The	role	of	Ctf4	as	a	hub	in	the	replisome,	coupling	DNA	synthesis	to	diverse	molecular	processes	that	
pertain	 to	chromosome	replication	and	segregation,	 is	 likely	 to	be	conserved	 in	diverse	eukaryotic	





will	 be	 devoted	 to	 developing	 appropriate	 strategies,	 including	 the	 stapled-peptide	 approach	
demonstrated	here,	to	target	the	biochemical	function	of	CTF4	in	human	cells.	As	the	type	of	peptide-
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B : MDINI XDILAEL XKETTAV-NH2 i,i+7
C : MDIXIDDILA XLDKETTAV-NH2 i,i+7
A : MDIXIDDIL XELDKETTAV-NH2 i,i+6



























































































Sld51−19 + 15% TFE
Sld51−19 + 30% TFE
A2
A2 + 15% TFE
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